Literature DB >> 11590844

Medical therapy of pulmonary hypertension. An overview of treatment and goals.

R J Barst1.   

Abstract

Therapeutic medical advances over the past two decades have resulted in significant improvements in the outcome for patients with various forms of pulmonary arterial hypertension. As the current understanding of the pathology and pathobiology of pulmonary arterial hypertension has moved forward, rationale for additional therapeutic modalities with novel therapeutic agents has led to increased clinical investigations. A brief overview of the pathology and pathobiology is presented as background for an introduction to the current medical therapy for pulmonary arterial hypertension as well as the goals for future treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590844     DOI: 10.1016/s0272-5231(05)70287-2

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  7 in total

Review 1.  Orphan drug development: the increasing role of clinical pharmacology.

Authors:  Mariam A Ahmed; Malek Okour; Richard Brundage; Reena V Kartha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-07-23       Impact factor: 2.745

2.  Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis.

Authors:  Walter Serra; Alfredo Chetta; Daniele Santilli; Flavio Mozzani; Pier Paolo Dall'Aglio; Dario Olivieri; Maria Alberta Cattabiani; Diego Ardissino; Tiziano Gherli
Journal:  Cardiovasc Ultrasound       Date:  2010-07-05       Impact factor: 2.062

Review 3.  Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies.

Authors:  Mobusher Mahmud; Hunter C Champion
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

4.  The importance of fragmented QRS in the early detection of cardiac involvement in patients with systemic sclerosis.

Authors:  Nermin Bayar; Hasan Fatih Çay; Zehra Erkal; İlhan Sezer; Şakir Arslan; Göksel Çağırcı; Serkan Çay; İsa Öner Yüksel; Erkan Köklü
Journal:  Anatol J Cardiol       Date:  2014-04-08       Impact factor: 1.596

5.  Demographics, treatment trends, and survival rate in incident pulmonary artery hypertension in Korea: A nationwide study based on the health insurance review and assessment service database.

Authors:  Shinjeong Song; Sang-Eun Lee; Sang Kwon Oh; Seong A Jeon; Ji Min Sung; Jae-Hyeong Park; Hyuk-Jae Chang
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

Review 6.  A review of sitaxsentan sodium in patients with pulmonary arterial hypertension.

Authors:  Aaron B Waxman
Journal:  Vasc Health Risk Manag       Date:  2007

7.  Increased hypoxemia in patients with COPD and pulmonary hypertension undergoing bronchoscopy with biopsy.

Authors:  Yoram Neuman; Matthew Koslow; Alona Matveychuk; Avigdor Bar-Sef; Alexander Guber; David Shitrit
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.